Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor

被引:76
作者
Roth, M
Nauck, M
Yousefi, S
Tamm, M
Blaser, K
Perruchoud, AP
Simon, HU
机构
[1] UNIV BASEL HOSP, DEPT INTERNAL MED, DIV PNEUMOL, CH-4031 BASEL, SWITZERLAND
[2] UNIV HOSP FREIBURG, DEPT CLIN CHEM, D-79106 FREIBURG, GERMANY
[3] UNIV ZURICH, SWISS INST ALLERGY & ASTHMA RES, CH-7270 DAVOS, SWITZERLAND
关键词
D O I
10.1084/jem.184.1.191
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Platelet-activating factor (PAF) is a potent proinflammatory phospholipid mediator of the lung. In this study, we demonstrate that PAF receptor mRNA and protein is expressed by human lung fibroblasts. Interaction of PAF with its specific receptor resulted in increases of tyrosine phosphorylation of several intracellular proteins, indicating that the PAF-receptor might be functionally active. PAF-induced transcription of protooncogenes c-fos and c-jun as well as or interleukin (IL)-6 and IL-8 genes in human fibroblasts. Transcription of the interleukins was followed by secretion of the respective proteins. Moreover, PAF enhanced proliferation of fibroblasts in a concentration-dependent manner. Using signaling inhibitors; we demonstrate that PAF-induced transcription of the c-fos, IL-6, and IL-8 genes, as well as proliferation, require activation of pertussis toxin-sensitive G proteins, tyrosine kinases, and protein kinase C (PKC). In contrast, transcription of c-jun was blocked by pertussis toxin, but not by inhibitors for tyrosine kinases or PKC. These data suggest that PAF stimulates distinct signaling pathways in human lung fibroblasts. In addition, the activation of human fibroblasts by PAF leads to enhanced proliferation and to the expression of proinflammatory cytokines, which may contribute to dir pathophysiological changes in pulmonary inflammation.
引用
收藏
页码:191 / 201
页数:11
相关论文
共 60 条
[1]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[2]   ADHESION MOLECULES AND INFLAMMATORY INJURY [J].
ALBELDA, SM ;
SMITH, CW ;
WARD, PA .
FASEB JOURNAL, 1994, 8 (08) :504-512
[3]  
AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139
[4]  
AU BT, 1994, J IMMUNOL, V152, P5411
[5]   NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS [J].
BAGGIOLINI, M ;
WALZ, A ;
KUNKEL, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1045-1049
[6]   PLATELET-ACTIVATING FACTOR AS A MEDIATOR OF ALLERGIC DISEASE [J].
BARNES, PJ ;
CHUNG, KF ;
PAGE, CP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (05) :919-934
[7]  
BLOCK LH, 1993, RESPIRATION, V1, P372
[8]   PLATELET-ACTIVATING-FACTOR MODULATES INTERLEUKIN-6 PRODUCTION BY MOUSE FIBROBLASTS [J].
BRAQUET, P ;
PIGNOL, B ;
MAISONNET, T ;
MENCIAHUERTA, JM .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1991, 94 (1-4) :165-166
[9]   CYTOKINES IN SYMPTOMATIC ASTHMA AIRWAYS [J].
BROIDE, DH ;
LOTZ, M ;
CUOMO, AJ ;
COBURN, DA ;
FEDERMAN, EC ;
WASSERMAN, SI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (05) :958-967
[10]  
BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877